Electrical remodeling of the human atrium: Similar effects in patients with chronic atrial fibrillation and atrial flutter

Journal of the American College of Cardiology

Volumn 30, Issue 7, 1997, Pages 1785-1792

  Franz, Michael R ^a,b   Karasik, Pamela L ^a   Li, Cuilan ^a   Moubarak, Jean ^a   Chavez, Mary ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INNERVATION; HEART MUSCLE; HEART MUSCLE POTENTIAL; HEART PACING; HUMAN; MALE; PRIORITY JOURNAL;

ACTION POTENTIALS; AGED; ATRIAL FIBRILLATION; ATRIAL FLUTTER; ATRIAL FUNCTION; CARDIAC PACING, ARTIFICIAL; CASE-CONTROL STUDIES; ELECTRIC COUNTERSHOCK; HEART CONDUCTION SYSTEM; HUMANS; MALE; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; TIME FACTORS;

EID: 0031539404     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00385-9     Document Type: Article

References (48)

1. Suttorp MJ, Kingma JH, Koomen EM, van 't Hof A, Tijssen JG, Lie KI. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol. 71:1993;710-713.
2. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation a population-based study over three decades . N Engl J Med. 317:1987;669-674.
3. Gold RL, Haffajee CI, Charos G, Sloan K, Baker S, Alpert JS. Amiodarone for refractory atrial fibrillation. Am J Cardiol. 57:1986;124-127.
4. Gosselink AT, Crijns HJ, Van Gelder IC, Hillige H, Wiesfeld AC, Lie KI. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA. 267:1992;3289-3293.
5. Reimold SC, Cantillon CO, Friedman PL, Antman EM. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol. 71:1993;558-563.
6. Diker E, Aydogdu S, Ozdemir M, et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol. 77:1996;96-98.
7. Frost L, Jacobsen CJ, Christiansen EH, et al. Hemodynamic predictors of atrial fibrillation or flutter after coronary artery bypass grafting. Acta Anaesthesiol Scand. 39:1995;690-697.
8. Gosselink AT, Crijns HJ, Hamer HP, Hillege H, Lie KI. Changes in left and right atrial size after cardioversion of atrial fibrillation role of mitral valve disease . J Am Coll Cardiol. 22:1993;1666-1672.
9. Simpson RJ Jr, Foster JR, Mulrow JP, Gettes LS. The electrophysiological substrate of atrial fibrillation. Pacing Clin Electrophysiol. 6:1983;1166-1170.
10. Wyndham CR. What's wrong with the atrium in patients with atrial fibrillation? Int J Cardiol. 2:1982;199-202.
11. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation a study in awake chronically instrumented goats . Circulation. 92:1995;1954-1968.
12. Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, Morady F. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation. 94:1996;1600-1606.
13. Zipes DP. Atrial fibrillation a tachycardia-induced atrial cardiomypathy? Circulation. 95:1997;562-564.
14. Franz MR, Chin MC, Sharkey HR, Griffin JC, Scheinman MM. A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivo. J Am Coll Cardiol. 16:1990;878-886.
15. Franz MR, Swerdlow CD, Liem LB, Schaefer J. Cycle length dependence of human action potential duration in vivo effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies . J Clin Invest. 82:1988;972-979.
16. Bass BG. Restitution of the action potential in cat papillary muscle. Am J Physiol. 228:1975;1717-1724.
17. Elharrar V, Surawicz B. Cycle length effect on restitution of action potential duration in dog cardiac fibers. Am J Physiol. 244:1983;92-98.
18. Franz MR, Kirchhof PF, Fabritz CL, Zabel M. Computer analysis of monophasic action potentials manual validation and clinically pertinent applications . Pacing Clin Electrophysiol. 18:1995;1666-1678.
19. Boyett MR, Jewell BR. Analysis of the effects of changes in rate and rhythm upon electrical activity in the heart. Prog Biophys Mol Biol. 36:1980;1-52.
20. Franz MR. Long-term recording of monophasic action potentials from human endocardium. Am J Cardiol. 51:1983;1629-1634.
21. Franz MR, Schaefer J, Schottler M, Seed WA, Noble MI. Electrical and mechanical restitution of the human heart at different rates of stimulation. Circ Res. 53:1983;815-822.
22. Attuel P, Childers R, Cauchemez B, Poveda J, Mugica J, Coumel P. Failure in the rate adaptation of the atrial refractory period its relationship to vulnerability . Int J Cardiol. 2:1982;179-197.
23. Boutjdir M, Le Heuzey JY, Lavergne T, et al. Inhomogeneity of cellular refractoriness in human atrium factor of arrhythmia? Pacing Clin Electrophysiol. 9:1986;1095-1100.
24. Brorson L, Olsson SB. Right atrial monophasic action potential in patients with paroxysmal supraventricular tachyarrhythmias. Acta Med Scand. 201:1977;105-110.
25. Goette A, Honeycutt C, Langberg JJ. Electrical remodelling in atrial fibrillation Time course and mechanisms . Circulation. 94:1996;2968-2974.
26. Lipsius SL, Fozzard HA, Gibbons WR. Voltage and time dependence of restitution in heart. Am J Physiol. 243:1982;76.
27. Lee KS, Marban E, Tsien RW. Inactivation of calcium channels in mammalian heart cells joint dependence on membrane potential and intracellular calcium . J Physiol (Lond). 364:1985;395-411.
28. + current in isolated membrane patches of guinea pig ventricular myocytes. Circ Res. 74:1994;96-104.
29. Kurz RW, Mohabir R, Ren XL, Franz MR. Ischaemia induced alternans of action potential duration in the intact-heart dependence on coronary flow, preload and cycle length . Eur Heart J. 14:1993;1410-1420.
30. Kaseda S, Zipes DP. Contraction-excitation feedback in the atria a cause of changes in refractoriness . J Am Coll Cardiol. 11:1988;1327-1336.
31. Yue L, Feng J, Gaspo R, Li G-R, Nattel S. Ionic remodelling underlying tachycardia-induced atrial fibrillation in dogs [abstract]. Circulation. 94:(Suppl I):1996;I-592.
32. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res. 80:1997;772-781.
33. Waldo AL, Plumb VJ, Henthorn RW. Observations on the mechanism of atrial flutter. Surawicz B, Reddy CP, Prystowski EN. Tachycardias. 1984;213-229 Martinus Nijhoff, The Hague.
34. Smeets JL, Allessie MA, Lammers WJ, Bonke FI, Hollen J. The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium the role of heart rate, autonomic transmitters, temperature, and potassium . Circ Res. 58:1986;96-108.
35. Lammers WJ, Schalij MJ, Kirchhof CJ, Allessie MA. Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol. 259:1990;H1254-H1263.
36. Plumb VJ, Karp RB, James TN, Waldo AL. Atrial excitability and conduction during rapid atrial pacing. Circulation. 63:1981;1140-1149.
37. Konings KT, Kirchhof CJ, Smeets JR, Wellens HJJ, Penn OC, Allessie MA. High-density mapping of electrically induced atrial fibrillation in humans. Circulation. 89:1994;1665-1680.
38. Morady F, Kadish AH, Toivonen LK, Kushner JA, Schmaltz S. The maximum effect of an increase in rate on human ventricular refractoriness. Pace. 11:1988;2223-2234.
39. Davidenko JM, Antzelevitch C. Electrophysiological mechanisms underlying rate-dependent changes of refractoriness in normal and segmentally depressed canine Purkinje fibers the characteristics of post-repolarization refractoriness . Circ Res. 58:1986;257-268.
40. Cobbe SM, Manley BS, Alexopoulos D. The influence of acute myocardial ischemia on the class III antiarrhythmic action of sotalol. Cardiovasc Res. 19:1985;661-667.
41. Nakaya Y, Nii H, Nomura M, Fujino K, Mori H. Effects of lidocaine and quinidine on post-repolarization refractoriness after the basic and premature action potentials consideration of aim of antiarrhythmic drug therapy . Am Heart J. 118:1989;907-912.
42. Costard JA, Liem LB, Franz MR. Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo. J Cardiovasc Pharmacol. 14:1989;810-817.
43. Koller BS, Karasik PE, Solomon AJ, Franz MR. The relationship between repolarization and refractoriness during programmed electrical stimulation in the human right ventricle implications for ventricular tachycardia induction . Circulation. 91:1995;2378-2384.
44. Sager PT, Uppal P, Follmer C, Antimisiaris M, Pruitt C, Singh BN. Frequency-dependent electrophysiologic effects of amiodarone in humans. Circulation. 88:1993;1063-1071.
45. Franz MR, Costard A. Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ. Circulation. 77:1988;1177-1184.
46. O'Donoghue S, Platia EV. Monophasic action potential recordings evaluation of antiarrhythmic drugs . Prog Cardiovasc Dis. 34:1991;1-14.
47. Stambler BS, Wood MA, Ellenbogen KA. Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration evidence of a fully excitable gap in the reentrant circuit . J Am Coll Cardiol. 27:1996;453-461.
48. Falk RH, Pollak A, Singh SN, Friedrich T, for the Intravenous Dofetilide Investigators. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. J Am Coll Cardiol 1997;29:385-90.